Updated
LabcorpLH · Healthcare
$366.57+0.90%
Market cap$29.8B
IndustryDiagnostics & Research
Labcorp (LH) Superinvestor holders
25 of the superinvestors we track hold Labcorp (LH) in their latest 13F filings, $2.2B in total.
Summary
The largest holder is Mark Donovan (Boston Partners), with $854M, 0.8% of the portfolio.
In their latest quarter: 6 opened a new position, 6 added, 12 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Mark Donovan Boston Partners |
Added | 3,051,690 | $854M | 0.8% | Q2 2026 |
| George Loening Select Equity Group |
Trimmed | 1,981,948 | $555M | 2.9% | Q2 2026 |
| Hotchkis & Wiley Hotchkis & Wiley Capital Management |
Trimmed | 742,022 | $208M | 0.6% | Q2 2026 |
| Ric Dillon Diamond Hill Capital Management |
Trimmed | 600,792 | $168M | 1.3% | Q2 2026 |
| John Rogers Ariel Investments |
Trimmed | 349,112 | $98M | 1.0% | Q2 2026 |
| Charles Brandes Brandes Investment Partners, LP |
Added | 249,524 | $70M | 0.5% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
Trimmed | 137,444 | $38M | 0.1% | Q2 2026 |
| Wallace Weitz Weitz Investment Management |
Held | 99,050 | $28M | 1.9% | Q2 2026 |
| Paul Marshall Marshall Wace |
Added | 96,666 | $27M | 0.0% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
Trimmed | 90,722 | $25M | 0.1% | Q2 2026 |
| Man Group Man Group plc |
Trimmed | 73,649 | $21M | 0.0% | Q2 2026 |
| Arrowstreet Capital | New position | 67,904 | $19M | 0.0% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 60,999 | $17M | 0.0% | Q2 2026 |
| Acadian Acadian Asset Management |
New position | 45,328 | $14M | 0.0% | Q3 2026 |
| David Shaw D. E. Shaw & Co. |
New position | 40,031 | $11M | 0.0% | Q2 2026 |
| Jensen Investment Management | Trimmed | 16,050 | $4M | 0.1% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Added | 13,737 | $4M | 0.0% | Q2 2026 |
| Alan Howard Brevan Howard |
New position | 8,660 | $2M | 0.0% | Q2 2026 |
| Mark Boyar Boyar Asset Management |
Trimmed | 3,611 | $1M | 0.7% | Q3 2026 |
| Ray Dalio Bridgewater Associates |
Trimmed | 2,798 | $783,440 | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
New position | 2,700 | $756,000 | 0.0% | Q2 2026 |
| Ken Fisher Fisher Investments |
Added | 1,556 | $479,515 | 0.0% | Q3 2026 |
| First Manhattan First Manhattan Co |
Trimmed | 980 | $274,400 | 0.0% | Q2 2026 |
| Fred DiSanto Ancora Holdings |
Trimmed | 241 | $67,480 | 0.0% | Q2 2026 |
| Josef Lakonishok LSV Asset Management |
New position | 129 | $40,000 | 0.0% | Q3 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 24 |
| Q1 2026 | 21 |
| Q4 2025 | 20 |
| Q3 2025 | 23 |
| Q2 2025 | 19 |
| Q1 2025 | 21 |
| Q4 2024 | 17 |
| Q3 2024 | 20 |
Questions about Labcorp
Which superinvestors own Labcorp?
25 of the superinvestors we track hold Labcorp (LH) in their latest 13F filings, $2.2B in total. Mark Donovan, George Loening, Hotchkis & Wiley, Ric Dillon, John Rogers, Charles Brandes.
Who is the largest superinvestor holder of LH?
The largest holder is Mark Donovan (Boston Partners), with $854M, 0.8% of the portfolio.
From Labcorp's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.